Q&A on the Johnson & Johnson COVID-19 vaccine with Mona Chitre, PharmD, Chief Pharmacy Officer and Vice President of Clinical Strategy and Innovation at Excellus BlueCross BlueShield

Posted on March 9, 2021

Dr. Chitre leads Excellus BlueCross BlueShield’s pharmacy strategy and is responsible for driving affordability, innovation and operational excellence. She completed her undergraduate and graduate training at Rutgers University and her post-doctoral primary care residency at the Buffalo VA Medical Center in Buffalo, New York.

Q: Dr. Chitre, the Johnson & Johnson (J&J) vaccine is the third COVID-19 vaccine being distributed in the U.S. Is it safe? Why do we need a third vaccine option?
A: All vaccines have the same goal – to protect us. The J&J vaccine was tested thousands of times to ensure safety and is authorized for use in the U.S. It’s important that everyone who wants the COVID-19 vaccine can receive it. In addition to the Moderna and Pfizer-BioNTech vaccines, the J&J vaccine is another way to help increase protection against the virus that causes COVID-19. Since all three vaccines are safe, the best vaccine is the one you have access to.

Q: How does the J&J vaccine differ from Moderna’s and Pfizer-BioNTech’s?
A: The J&J vaccine is a single dose which offers maximum protection quicker than Moderna’s and Pfizer-BioNTech’s vaccines. The J&J vaccine has proven to be 66% effective at preventing moderate to severe cases of COVID-19. With all three vaccine options, no fragment of the live virus is in the vaccine so the vaccine itself cannot make you sick with COVID-19.

Q: Should we be concerned with a less effective rate?
A: No, there is no need to be concerned. The only way to accurately compare the effectiveness of these vaccines is by direct comparison in head-to-head clinical trials, which did not happen across the three vaccine options. Testing took place in different regions, at different points in time, and with varying COVID-19 occurrences. It is best not to compare the effective rates between the vaccines.

The data proves that the J&J vaccine is 85% effective against severe COVID-19 cases, and 100% effective at preventing death from COVID-19. Based on the data, the J&J vaccine is a very safe and effective option.

Q: There is mention of a booster vaccine to help protect against the COVID-19 variants. What information is known or suggested about this?

A: Scientists are currently looking into if a booster dose is needed to address variants. It is emerging science at this time, but it is still recommended that you get your vaccine as soon as it is available for you.

Q: We know that vaccines were given to high-risk groups first. The data suggests that the number of deaths in nursing homes is going down by more than 60%. Do you feel this is because of the vaccine?
A: Absolutely. Nursing home residents were among the first people to receive the vaccine. The data shows how powerful the vaccines are against the virus, which is encouraging to hear. Reports like these make me so hopeful as the vaccines continue to rollout. I’m excited for my children to be reunited with their grandparents. I’m optimistic about the future.

Other Member News

Excellus Blue Cross Blue Shield Excellence Logos
October 1, 2025

Specialists' One-Day Surgery Center Recognized Nationally for Higher Quality and Cost-Effective Spine Surgery and Hip & Knee Replacements

This program identifies hospitals and ambulatory care centers (ASCs) that demonstrate expertise in delivering improved patient safety, better health outcomes, and are more cost-effective.

Wicked
October 1, 2025

Wicked to Return to Landmark Theatre Dec. 3–14, 2025

Winner of over 100 international awards including the Grammy Award and three Tony Awards, WICKED has been performed in over 100 cities in 16 countries around the world.

new partners graphic
October 1, 2025

New Partners-CEO Insights October 2025

Please join us in welcoming new CenterState CEO Partner-level members.   

member news graphic
September 30, 2025

Member Essentials-CEO Insights October 2025

Below is a snapshot of the latest news and top headlines from our members. We want to hear from you!

new investors graphic
September 30, 2025

New Investors-CEO Insights October 2025

CenterState CEO wishes to recognize the members who have recently joined as Investors.

Harris Beach Murtha
September 30, 2025

36 Harris Beach Murtha Attorneys Selected to 2025 Upstate New York Super Lawyers® and Super Lawyers: Rising Stars® Lists

Super Lawyers is a nationally recognized professional survey and ranking service of accomplished attorneys who have achieved a high degree of peer recognition and professional achievement in more than 70 practice areas.

Mitch Nelson, Technician of the Year
September 30, 2025

Eastern Security Services Technician Receives National Distinction

The award highlights excellence in system design, installation, and maintenance while honoring the vital role technicians play in protecting people and property.

ambassadors sfcu graphic
September 30, 2025

Ambassadors-CEO Insights October 2025

Presented by SFCU

Dan and Andrea
September 29, 2025

FMF&E CPA, P.C. Announces New Managing Partner and Key Leadership Appointments

As the Firm celebrates its 45th year in business, this transition marks a significant milestone in the Firm’s continued growth and evolution.